Peer-influenced content. Sources you trust. No registration required. This is HCN.
Parkinson’s News Today
Switching Parkinson’s patients to Crexont added more than three hours of daily symptom control in interim Phase 4 data. Here’s how to read an open-label, sponsor-run signal.
Neurology April 30th 2026
MDLinx
Stories from professional golfers with Parkinson’s illustrate how early motor symptoms disrupt precision, identity, and daily activities.
Geriatrics April 15th 2026
Repeated fecal transplants improved motor symptoms and constipation in early Parkinson’s, highlighting the gut microbiome as a potential therapeutic research pathway.
Gastroenterology April 15th 2026
“This study establishes chlorpyrifos as a specific environmental risk factor for Parkinson’s disease, not just pesticides as a general class,” said Dr. Jeff Bronstein, professor of Neurology at UCLA Health and the study’s senior author.
Neurology April 2nd 2026
Medical Professionals Reference (MPR)
Although most of these patients had no response to multiple seizure medications, the 9 who were treated with vitamin B6 supplementation had resolution of their seizures.
MedCentral
Caregiver burden is common, cumulative, and often unspoken, manifesting as fatigue, depression, irritability, and social withdrawal.
Neurology February 19th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS